The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells.

Saved in:
Bibliographic Details
Title: The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells.
Authors: Maharaj K; Department of Malignant Hematology.; Department of Immunology, and.; Department of Cancer Biology PhD Program, University of South Florida and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Powers JJ; Department of Immunology, and., Achille A; Department of Immunology, and., Mediavilla-Varela M; Department of Malignant Hematology.; Department of Immunology, and., Gamal W; Department of Immunology, and.; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL., Burger KL; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Fonseca R; Department of Immunology, and., Jiang K; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Miskin HP; TG Therapeutics, Inc., New York, NY., Maryanski D; TG Therapeutics, Inc., New York, NY., Monastyrskyi A; Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and., Duckett DR; Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and., Roush WR; Department of Molecular Medicine, The Scripps Research Institute, Scripps Florida, Jupiter, FL., Cleveland JL; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Sahakian E; Department of Malignant Hematology.; Department of Immunology, and., Pinilla-Ibarz J; Department of Malignant Hematology.; Department of Immunology, and.
Source: Blood advances [Blood Adv] 2020 Jul 14; Vol. 4 (13), pp. 3072-3084.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32634240
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Maharaj+K%22">Maharaj K</searchLink>; Department of Malignant Hematology.; Department of Immunology, and.; Department of Cancer Biology PhD Program, University of South Florida and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Powers+JJ%22">Powers JJ</searchLink>; Department of Immunology, and.<br /><searchLink fieldCode="AU" term="%22Achille+A%22">Achille A</searchLink>; Department of Immunology, and.<br /><searchLink fieldCode="AU" term="%22Mediavilla-Varela+M%22">Mediavilla-Varela M</searchLink>; Department of Malignant Hematology.; Department of Immunology, and.<br /><searchLink fieldCode="AU" term="%22Gamal+W%22">Gamal W</searchLink>; Department of Immunology, and.; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Burger+KL%22">Burger KL</searchLink>; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Fonseca+R%22">Fonseca R</searchLink>; Department of Immunology, and.<br /><searchLink fieldCode="AU" term="%22Jiang+K%22">Jiang K</searchLink>; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Miskin+HP%22">Miskin HP</searchLink>; TG Therapeutics, Inc., New York, NY.<br /><searchLink fieldCode="AU" term="%22Maryanski+D%22">Maryanski D</searchLink>; TG Therapeutics, Inc., New York, NY.<br /><searchLink fieldCode="AU" term="%22Monastyrskyi+A%22">Monastyrskyi A</searchLink>; Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and.<br /><searchLink fieldCode="AU" term="%22Duckett+DR%22">Duckett DR</searchLink>; Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and.<br /><searchLink fieldCode="AU" term="%22Roush+WR%22">Roush WR</searchLink>; Department of Molecular Medicine, The Scripps Research Institute, Scripps Florida, Jupiter, FL.<br /><searchLink fieldCode="AU" term="%22Cleveland+JL%22">Cleveland JL</searchLink>; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Sahakian+E%22">Sahakian E</searchLink>; Department of Malignant Hematology.; Department of Immunology, and.<br /><searchLink fieldCode="AU" term="%22Pinilla-Ibarz+J%22">Pinilla-Ibarz J</searchLink>; Department of Malignant Hematology.; Department of Immunology, and.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2020 Jul 14; Vol. 4 (13), pp. 3072-3084.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32634240
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2020001800
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3072
    Titles:
      – TitleFull: The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Maharaj K
      – PersonEntity:
          Name:
            NameFull: Powers JJ
      – PersonEntity:
          Name:
            NameFull: Achille A
      – PersonEntity:
          Name:
            NameFull: Mediavilla-Varela M
      – PersonEntity:
          Name:
            NameFull: Gamal W
      – PersonEntity:
          Name:
            NameFull: Burger KL
      – PersonEntity:
          Name:
            NameFull: Fonseca R
      – PersonEntity:
          Name:
            NameFull: Jiang K
      – PersonEntity:
          Name:
            NameFull: Miskin HP
      – PersonEntity:
          Name:
            NameFull: Maryanski D
      – PersonEntity:
          Name:
            NameFull: Monastyrskyi A
      – PersonEntity:
          Name:
            NameFull: Duckett DR
      – PersonEntity:
          Name:
            NameFull: Roush WR
      – PersonEntity:
          Name:
            NameFull: Cleveland JL
      – PersonEntity:
          Name:
            NameFull: Sahakian E
      – PersonEntity:
          Name:
            NameFull: Pinilla-Ibarz J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 07
              Text: 2020 Jul 14
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 13
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1